Institute for Molecular Manufacturing

What Institute for Molecular Manufacturing does

The Institute for Molecular Manufacturing (IMM) is a 501(c)(3) nonprofit research foundation founded in 1991 and headquartered in Palo Alto, California, dedicated to advancing Atomically Precise Manufacturing (APM) and molecular nanotechnology. The organization conducts and catalyzes research on development pathways for APM, designs of nanoscale devices, and the technological, economic, and ethical implications of atomically precise manufacturing systems. Its research portfolio spans theoretical nanomedicine — including designs for respirocytes (artificial mechanical red blood cells), clottocytes (artificial mechanical platelets), microbivores (artificial mechanical phagocytes), and the Vasculoid personal appliance — alongside policy frameworks for responsible nanotechnology development. IMM has provided briefings to the U.S. Senate, NATO, the National Academy of Sciences, the U.S. Intelligence Community, and U.S. Military Intelligence Agencies on molecular nanotechnology applications.

IMM's product surface is non-commercial and centers on research publications and policy artifacts rather than goods or services. Primary outputs include the Nanomedicine book series authored by Senior Research Fellow Robert A. Freitas Jr. (Volume I published October 1999; Volume IIA published October 2003), the IMM Reports on Nanomedicine series, the Foresight Guidelines for Responsible Nanotechnology Development (co-proposed with Foresight Institute in 1999), and co-sponsorship of foundational field literature including Nanosystems (1993) and the 2007 Productive Nanosystems Technology Roadmap.

IMM's revenue model is donation-dependent and operates without commercial product sales. Funding derives from a Patron Program (annual commitments of $500, $1,000, or more for five years), general charitable contributions (tax-deductible in the U.S.), and targeted research fundraising drives (e.g., the IMM Freitas Research Fund, with a $30,000 goal in 2004). Past disclosed fundraising totals include ~$35,000 raised in 1998 and ~$35,000 in 1999-2000 for the Nanomedicine project, jointly with Foresight Institute. Audience segments are horizontal: the academic and industry research community, U.S. and allied government and policy-making bodies, and patrons/donors committed to advancing molecular nanotechnology research. Distribution occurs through publications, conference co-sponsorship, policy engagement, and free online access to technical papers.

Name

Institute for Molecular Manufacturing

Legal name

Institute for Molecular Manufacturing

Website

https://imm.org

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

51–100 employees

Short description

The Institute for Molecular Manufacturing is a 501(c)(3) nonprofit research foundation founded in 1991 in Palo Alto, California, dedicated to advancing atomically precise manufacturing and molecular nanotechnology through theoretical nanomedicine research, policy engagement, and foundational publications serving researchers and government bodies.

Ownership category

akta.pro rank

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Donations and Patron Program: IMM operates as a 501(c)(3) nonprofit accepting donations at any level. Patrons pledge annual contributions of $500, $1000, or more for five years. Donations are tax-deductible in the U.S.
2. Research Fundraising: IMM conducts specific fundraising drives for research projects, such as the $30,000 goal for the IMM Freitas Research Fund to support completion of Nanomedicine Volumes IIB and III.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

IMM is a 501(c)(3) nonprofit research foundation that conducts and catalyzes research on Atomically Precise Manufacturing (APM), also known as molecular nanotechnology. The institute develops theoretical foundations, nanoscale device designs, and policy frameworks; publishes technical reports and books on nanomedicine; and provides briefings to government bodies. Research funding comes from patron donations and targeted fundraising drives.

Product overview

The Institute for Molecular Manufacturing (IMM) is a 501(c)(3) nonprofit research foundation established in 1991, conducting and catalyzing research on Atomically Precise Manufacturing. IMM's offerings center on research publications and policy guidelines rather than commercial products. The primary offerings include: the IMM Reports on Nanomedicine series (covering theoretical nanomedical devices such as artificial mechanical platelets, artificial mechanical phagocytes, and vasculoid appliances); the Nanomedicine book series by Robert A. Freitas Jr.; and the Foresight Guidelines for Responsible Nanotechnology Development. IMM also operates the IMM Freitas Research Fund to support ongoing research into molecular nanotechnology implementation.

Differentiator

Problem solved

Functional benefit

Products and services

• IMM Reports on Nanomedicine

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• Foresight Institute, The Waitt Family Foundation, Battelle, Sun Microsystems, Zyvex LabsflagshipStrategic or Co-development Partner · 1 January 2007Co-sponsored the Productive Nanosystems: A Technology Roadmap (2007) - a major technology roadmap for productive nanosystems development, bringing together industry, foundation, and academic partners to chart the path forward for molecular manufacturing.
• Foresight InstitutecoreStrategic or Co-development Partner · 1 January 1991Long-standing collaboration since 1991 including co-funding the pioneering conference series in molecular nanotechnology, co-sponsoring foundational textbooks (Nanosystems, Nanomedicine), and jointly proposing Guidelines for the Development of Molecular Nanotechnology in 1999. Foresight Update publications distributed in conjunction with IMM Reports.

Scale indicators3 records

Recent moves6 records

Expansion highlights3 records

Others

• Waitt Family Foundation: A philanthropic foundation that co-funded the Productive Nanosystems roadmap. It is comparable as a co-sponsor and adjacent funder of molecular nanotechnology research, though operating as a grantmaker rather than a research institution.
• Nano.gov / National Nanotechnology Initiative (NNI) coordinating bodies: The U.S. National Nanotechnology Initiative is the federal coordinating body IMM has historically briefed and influenced. Comparable as the institutional counterpart shaping U.S. nanotechnology R&D priorities, though a government program rather than an independent nonprofit.
• Alcor Life Extension Foundation: A nonprofit in the same futurist/longevity ecosystem with a comparable donor-membership revenue model and research publication activities. Thematically related as part of the same community around transformative technologies, though focused on cryopreservation rather than molecular manufacturing.

Emerging players

• Cryonics Institute: A nonprofit research and storage organization with overlapping futurist/longevity community ties and similar donor-funded, community-led model. Comparable as a small mission-driven nonprofit serving a niche advanced-technology community, though in life extension rather than manufacturing.
• Coulter Translational Research Partnership / academic nanotech centers (e.g., Rice University's Smalley-Curl Institute): University-based nanotechnology research institutes that perform fundamental and applied nanoscale R&D. Comparable as research institutions producing foundational nanotechnology science and training next-generation researchers, though typically embedded within larger universities and focused more on applied outcomes.
• Zyvex Labs: Zyvex is a commercial molecular nanotechnology company that co-sponsored the Productive Nanosystems roadmap with IMM. It is comparable as an early-stage player pursuing atomically precise manufacturing and nanomanipulation tools, though operating under a commercial (versus nonprofit) model.

Broad incumbents

• Technology Futures Analysis Techniques (TFAT) / RAND Corporation advanced-manufacturing studies: RAND and similar think tanks conduct technology foresighting and policy research that overlaps with IMM's policy-briefing work. Comparable as an institution that shapes government understanding of emerging technologies, though much larger and broader in scope than IMM.
• Battelle Memorial Institute: Battelle is a large applied science nonprofit that co-sponsored the Productive Nanosystems roadmap with IMM. Comparable as a nonprofit research organization that manages large-scale science programs and interfaces with government/defense, though operating across many disciplines beyond nanotechnology.

Direct peers

• Foresight Institute: Foresight Institute is the closest peer to IMM — a sister nonprofit founded around the same era focused on advancing molecular nanotechnology and beneficial advanced technologies. IMM and Foresight have co-sponsored textbooks, conferences, policy guidelines (1999), and the Productive Nanosystems roadmap since 1991, making them essentially co-stewards of the same field.
• Center for Responsible Nanotechnology: CRN is a nonprofit think tank focused on the implications, capabilities, and policy implications of advanced nanotechnology — overlapping closely with IMM's policy-guideline and ethics work for molecular nanotechnology. It addresses similar stakeholders (researchers, policymakers) on similar subject matter.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/institute-for-molecular-manufacturing

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Molecular Manufacturing